로딩 중…
StockDiggingStockDigging

피엔케이피부임상연구센타

347740· KOSDAQ
₩1,826-4.15%
2026-06-19

Price Chart

피엔케이피부임상연구센타-39.03%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap54.80B KRW
Revenue22.56B KRW
Net Income3.71B KRW
Total Assets87.46B KRW
Net Assets80.68B KRW
Employees104
Value
P/E14.78x
P/B0.68x
P/S2.43x
EV/EBITDA18.03x
FCF Yield6.12%
Profitability
ROE4.60%
ROA4.24%
Op. Margin13.24%
Revenue Growth-3.43%
Earnings Growth-37.99%
Financial Health
Debt Ratio8.41%
FCF3.35B KRW
Cash922.8M KRW
Current Ratio8.38x
Net Debt/EBITDA-0.31x
Dividend
Div. Yield2.63%
Div. Growth25.00%
Performance
1Y Return-39.03%
1M Return-14.07%
From 52W High-44.67%
1Y MDD-44.05%
Trading
Volume51,506 shares
Foreign Own.1.44%
Per Share
EPS127 KRW
BPS2,800 KRW

Company Info

CEO 박진오, 이해광(각자대표)
Employees 104
Founded 2010
HQ 서울특별시 영등포구, KR

PNK Skin Clinical Research Center was established in 2010 as Korea's first joint human application testing institution by Daebong LS and a medical college research institute, listing on KOSDAQ in 2020. The company conducts safety and efficacy verification tests for products like cosmetics and health functional foods, while also providing technology and information for new ingredient development and functional cosmetic testing. It leads the market with new protocol development and global-level data reliability, earning technological recognition through a strategic technology cooperation MOU with BASF in 2019.